Inspira Technologies - IINN Company Value to Revenue Ratio

Public company logo of Inspira Technologies Oxy B.H.N. Ltd (IINN)

Stable revenue from the sale of blood oxygenation consumables contrasts with the long-term strategy of production outsourcing utilizing Israeli engineering for Inspira Technologies Oxy (IINN). The EV/Sales trajectory visualizes this balance, where the 51241.38 level serves as a critical benchmark. System resilience is confirmed by diversified electronics supply channels, which eliminate disruptions in the assembly of therapeutic devices.

IINN Inspira Technologies: EV/Sales Multiple in the range 11/23/2025 - 05/20/2026

IINN (inspira-technologies.com): analytical breakdowns and indicator data

- money and cash flow information:
Mass-produced product of Inspira Technologies Oxy

The high margins of Inspira Technologies Oxy (IINN), driven by the resilience of electronics supply chains, make the analysis of revenue generation efficiency a priority. The price-to-sales multiple dynamics on GURU.Markets reflect the market valuation of the business net of debt, allowing investors to filter out speculative noise from the actual scaling of the enterprise. An increase in this indicator signals an asset revaluation, necessitating caution when entering positions at local peaks.

Competitor analysis for Inspira Technologies Oxy

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|CTSO - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Sensus Healthcare, Inc. SRTS|ZYXI: Company Value to Revenue Ratio|ECOR: Company Value to Revenue|Vicarious Surgical Inc - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)